Nnenna Osuji

2.0k citations
23 papers · 678 indexed · h-index 13
Topics
Chronic Lymphocytic Leukemia Research (19 papers)Lymphoma Diagnosis and Treatment (15 papers)Viral-associated cancers and disorders (7 papers)

In The Last Decade

Nnenna Osuji

23 papers receiving 662 citations

Peers

Nnenna Osuji
Comparison fields: 5 of 45
  • Genetics 548
  • Pathology and Forensic Medicine 458
  • Immunology 322
  • Oncology 178
  • Molecular Biology 86
Replace Sandra Kanan with:
Sandra Kanan United States
Pramoda Challagundla United States
MJ Keating United States
Daphne R. Friedman United States
Monica Tozzi Italy
G. Tolksdorf Germany
Mt Fierro Italy
Nongnit Lewin Sweden
Rachael Siegel United States
Thomas L. Olson United States
Nnenna Osuji relative to Sandra Kanan United States Sandra Kanan's profile →
Citations per field
00.5×1.5×
Sandra Kanan · 1×
Citations per year

Countries citing papers authored by Nnenna Osuji

Since Specialization
Citations

This map shows the geographic impact of Nnenna Osuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nnenna Osuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nnenna Osuji more than expected).

Fields of papers citing papers by Nnenna Osuji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nnenna Osuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nnenna Osuji. The network helps show where Nnenna Osuji may publish in the future.

Co-authorship network of co-authors of Nnenna Osuji

This figure shows the co-authorship network connecting the top 25 collaborators of Nnenna Osuji. A scholar is included among the top collaborators of Nnenna Osuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nnenna Osuji. Nnenna Osuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 18
2 175
3 32
4 41
5 35
6 25
7 67
8 23
9 11
10 7
11 3
12 24
13 79
14 24
15 52
16 12
17 3
18 1
19 10
20 26

About Nnenna Osuji

Nnenna Osuji is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 23 papers that have together received 678 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and Viral-associated cancers and disorders (7 papers). The work is most often cited by research in Genetics (548 citations), Pathology and Forensic Medicine (458 citations) and Immunology (322 citations). Nnenna Osuji has collaborated with scholars based in United Kingdom, Italy and Norway. Frequent co-authors include Estella Matutes, Daniel Catovsky, Andrew Wotherspoon, Ilaria Del Giudice, Claire Dearden, Monica Else, John Swansbury, Francesco Forconi, Francesco Lauria and S.A. Johnson. Their work appears in journals such as Blood, Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026